121 related articles for article (PubMed ID: 8960463)
21. Increased serum concentrations of type I procollagen C-terminal propeptide and osteocalcin during a short course of calcitriol administration to adult male volunteers.
Gram J; Bollerslev J; Nielsen HK; Junker P
Acta Endocrinol (Copenh); 1991 Dec; 125(6):609-13. PubMed ID: 1789055
[TBL] [Abstract][Full Text] [Related]
22. Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery.
Minisola S; Romagnoli E; Scarnecchia L; Rosso R; Pacitti MT; Scarda A; Mazzuoli G
Eur J Endocrinol; 1994 Jun; 130(6):587-91. PubMed ID: 8205259
[TBL] [Abstract][Full Text] [Related]
23. Acute correction of metabolic acidosis increases serum procollagen type I carboxyterminal propeptide in patients with chronic renal failure.
Chu P; Lu KC; Lin YF
J Formos Med Assoc; 2001 Nov; 100(11):748-52. PubMed ID: 11802533
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment.
Terzolo M; Piovesan A; Osella G; Pia A; Reimondo G; Pozzi C; Raucci C; Torta M; Paccotti P; Angeli A
Calcif Tissue Int; 1993 Mar; 52(3):188-91. PubMed ID: 8481830
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.
Antoniazzi F; Bertoldo F; Mottes M; Valli M; Sirpresi S; Zamboni G; Valentini R; Tató L
J Pediatr; 1996 Sep; 129(3):432-9. PubMed ID: 8804334
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
27. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.
Akimoto S; Akakura K; Shimazaki J
Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556
[TBL] [Abstract][Full Text] [Related]
28. Biochemical markers of bone turnover in girls during puberty.
Blumsohn A; Hannon RA; Wrate R; Barton J; al-Dehaimi AW; Colwell A; Eastell R
Clin Endocrinol (Oxf); 1994 May; 40(5):663-70. PubMed ID: 7516828
[TBL] [Abstract][Full Text] [Related]
29. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].
Imai T; Honda M; Maeda S; Hosoya Y; Arai T; Sumi S; Umeda H; Yano M; Koga F; Arai K; Yoshida K
Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867
[TBL] [Abstract][Full Text] [Related]
30. Serum procollagen type I carboxyterminal propeptide in CAPD and hemodialysis patients.
Gerakis A; Apostolou T; Bagiatoudi G; Tzouganatou A; Margellos V; Nikolopoulou N; Billis A
Perit Dial Int; 1996; 16 Suppl 1():S309-11. PubMed ID: 8728213
[No Abstract] [Full Text] [Related]
31. Monitoring of bone metabolism after bone marrow transplantation by measuring two different markers of bone turnover.
Withold W; Wolf HH; Kollbach S; Heyll A; Schneider W; Reinauer H
Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):193-7. PubMed ID: 8721406
[TBL] [Abstract][Full Text] [Related]
32. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
33. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
[TBL] [Abstract][Full Text] [Related]
34. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
[TBL] [Abstract][Full Text] [Related]
35. Abnormalities in biomarkers of mineral and bone metabolism in kidney donors.
Kasiske BL; Kumar R; Kimmel PL; Pesavento TE; Kalil RS; Kraus ES; Rabb H; Posselt AM; Anderson-Haag TL; Steffes MW; Israni AK; Snyder JJ; Singh RJ; Weir MR
Kidney Int; 2016 Oct; 90(4):861-8. PubMed ID: 27370408
[TBL] [Abstract][Full Text] [Related]
36. Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens.
Vejlgaard T; Abildgaard N; Jans H; Nielsen JL; Heickendorff L
Eur J Haematol; 1997 Feb; 58(2):104-8. PubMed ID: 9111591
[TBL] [Abstract][Full Text] [Related]
37. Serum propeptides of type I and III procollagens in renal transplant recipients. A comparison of cyclosporine and azathioprine treatment.
Heickendorff L; Frost L; Madsen JK; Pedersen EB
Nephron; 1994; 67(2):203-8. PubMed ID: 8072610
[TBL] [Abstract][Full Text] [Related]
38. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
39. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
Tanaka K; Shiraishi K; Sakamoto A; Jojima H; Masuchi K; Okubo Y; Tanaka M; Fuzimatsu Y; Fukahori S; Osabe S; Imamura Y; Honda J; Oizumi K
Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
[TBL] [Abstract][Full Text] [Related]
40. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
